Clinically Significant CUX1 Mutations Are Frequently Subclonal and Common in Myeloid Disorders With a High Number of Co-mutated Genes and Dysplastic Features

Online journal article in Molecular Pathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

To compare the clinical characteristics of myeloid disorders with CUX1 Tier I/Tier II variants compared to CUX1 variants of uncertain significance.
To...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

To compare the clinical characteristics of myeloid disorders with CUX1 Tier I/Tier II variants compared to CUX1 variants of uncertain significance.
To discuss the importance of accurate classification of variants in clinical reporting of multi-gene panels.
To describe the mutational landscape and clonal architecture of myeloid disorders with clinically significant CUX1 variants.

View More View Less